Target intelligence / Profile preview

L-lactate dehydrogenase (LDH)

Target: LDH
Molecular classification: Enzyme

Overview

L-lactate dehydrogenase (LDH) is an enzyme that catalyzes the interconversion of pyruvate and lactate, with concomitant interconversion of NADH and NAD+. It plays a crucial role in anaerobic glycolysis and is found in various tissues. Elevated serum LDH levels are indicative of tissue damage or disease states, including myocardial infarction, hemolytic anemia, cancers, and inflammatory diseases. LDHA, a subunit of LDH, is a therapeutic target in cancer due to its role in the Warburg effect.

Mechanism of action

Enzyme inhibition

Biological functions

Anaerobic glycolysisLactate shuttlingCellular metabolism

Disease associations

CancerMyocardial infarctionHemolytic anemiaInflammationARDSCOVID-19

Safety considerations

Non-specific marker of tissue damage

Biomarkers

Elevated serum LDH levels

Beyond the preview

Go deeper on L-lactate dehydrogenase (LDH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on L-lactate dehydrogenase (LDH).